MAP PHARMACEUTICALS, INC. Selling, General and Administrative Expense
MAP PHARMACEUTICALS, INC. reported Selling, General and Administrative Expense of $5.64 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2012-09-30 was $5.64M, a 4.21% decline year-over-year.
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2012-06-30 was $6.40M, a 33.42% increase year-over-year.
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2012-03-31 was $7.91M, a 63.31% increase year-over-year.
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2011-12-31 was $6.53M, a 63.23% increase year-over-year.
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2011 was $22.06M, a 40.39% increase from fiscal 2010.
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2010 was $15.71M, a 19.59% increase from fiscal 2009.
- MAP PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2009 was $13.14M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 96 month | Selling, General and Administrative Expense 99 month | Selling, General and Administrative Expense 102 month | Selling, General and Administrative Expense 105 month | Selling, General and Administrative Expense 108 month | Selling, General and Administrative Expense 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $5.64M 10-Q · filed 2012-11-06 | $12.04M derived: sum of 2 quarters · filed 2012-11-06 | $19.95M 10-Q · filed 2012-11-06 | $26.48M derived: sum of 4 quarters · filed 2012-11-06 | $104.92M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $6.40M 10-Q · filed 2012-07-27 | $14.31M 10-Q · filed 2012-07-27 | $20.84M derived: sum of 3 quarters · filed 2012-07-27 | $26.73M derived: sum of 4 quarters · filed 2012-11-06 | $99.28M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | $7.91M 10-Q · filed 2012-05-08 | $14.44M derived: sum of 2 quarters · filed 2012-05-08 | $20.33M derived: sum of 3 quarters · filed 2012-11-06 | $25.13M derived: sum of 4 quarters · filed 2012-11-06 | $92.88M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $12.42M derived: sum of 2 quarters · filed 2012-11-06 | $17.22M derived: sum of 3 quarters · filed 2012-11-06 | $22.06M 10-K · filed 2012-03-30 | $84.97M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $5.89M 10-Q · filed 2012-11-06 | $10.69M derived: sum of 2 quarters · filed 2012-11-06 | $15.53M 10-Q · filed 2012-11-06 | $19.53M derived: sum of 4 quarters · filed 2012-11-06 | $78.44M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | $4.80M 10-Q · filed 2012-07-27 | $9.64M 10-Q · filed 2012-07-27 | $13.64M derived: sum of 3 quarters · filed 2012-07-27 | $17.56M derived: sum of 4 quarters · filed 2012-07-27 | $72.55M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | $4.84M 10-Q · filed 2012-05-08 | $8.84M derived: sum of 2 quarters · filed 2012-05-08 | $12.77M derived: sum of 3 quarters · filed 2012-05-08 | $16.68M derived: sum of 4 quarters · filed 2012-05-08 | ||||||
| 2010-12-31 | $4.00M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $7.92M derived: sum of 2 quarters · filed 2012-03-30 | $11.83M derived: sum of 3 quarters · filed 2012-03-30 | $15.71M 10-K · filed 2012-03-30 | ||||||
| 2010-09-30 | $3.92M 10-Q/A · filed 2012-03-30 | $7.83M derived: sum of 2 quarters · filed 2012-03-30 | $11.71M 10-Q/A · filed 2012-03-30 | |||||||
| 2010-06-30 | $3.91M 10-Q/A · filed 2012-03-30 | $7.79M 10-Q/A · filed 2012-03-30 | ||||||||
| 2009-12-31 | $13.14M 10-K · filed 2012-03-30 |